Many studies have shown elevated YB-1 protein levels in malignant tissues compared with normal tissues, and higher levels of YB-1 have also been associated with higher tumor grade and poorer patient prognosis in different malignancies, including breast [38, 39], lung [40] and ovarian cancers [41]. Here, YBX1 is linked to ovarian carcinoma.